143 results
424B3
AMYT
Amryt Pharma Plc
31 Jan 22
Prospectus supplement
7:33am
strategies and the environment in which Amryt expects to operate in the future. Forward-looking statements involve inherent known and unknown risks … in this announcement are based on numerous assumptions and Amryt's present and future business strategies and the environment in which Amryt expects to operate
424B3
AMYT
Amryt Pharma Plc
31 Mar 22
Prospectus supplement
8:44am
are based on numerous assumptions and Amryt's present and future business strategies and the environment in which Amryt expects to operate in the future … on numerous assumptions and Amryt's present and future business strategies and the environment in which Amryt expects to operate in the future. Forward
424B3
AMYT
Amryt Pharma Plc
31 Jan 22
Prospectus supplement
7:35am
strategies and the environment in which Amryt expects to operate in the future. Forward-looking statements involve inherent known and unknown risks … in this announcement are based on numerous assumptions and Amryt's present and future business strategies and the environment in which Amryt expects to operate
424B3
AMYT
Amryt Pharma Plc
31 Mar 22
Prospectus supplement
8:44am
are based on numerous assumptions and Amryt's present and future business strategies and the environment in which Amryt expects to operate in the future … on numerous assumptions and Amryt's present and future business strategies and the environment in which Amryt expects to operate in the future. Forward
6-K
EX-99.1
AMYT
Amryt Pharma Plc
4 Aug 22
Results of Annual General Meeting
7:38am
on numerous assumptions and Amryt's present and future business strategies and the environment in which Amryt expects to operate in the future. Forward-looking
424B3
rl0pm6oc cb0
23 Aug 21
Prospectus supplement
8:18am
424B3
tn0sho2ulnwov9spfj2
23 Aug 21
Prospectus supplement
8:17am
6-K
EX-99.1
xabprf56awluw z3amr0
31 Mar 22
Results of General Meeting
8:41am
6-K
EX-99.4
pkocl42c
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.4
m3sufmjso0w1 i9zhf3y
12 Apr 23
Current report (foreign)
5:28pm
6-K
EX-99.3
8fxxp5hc94d090dzgp
29 Oct 21
Current report (foreign)
6:05am
6-K
EX-99.2
cqsbw85
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.5
1ipwbwvc5
31 Jan 22
Current report (foreign)
7:32am
6-K
EX-99.6
m2bkb mo130zg
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.6
6k5rgsijr1
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.1
ayl6adsa qrg2ufiv
7 Jun 21
FDA confirms NDA for Oleogel-S10 will not require an Advisory Committee Meeting
9:13am
6-K
EX-99.4
jpfi3169x7fuirid
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.3
16i0l3 he3wx
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.1
sov5l2h40fhx
1 Jun 22
Current report (foreign)
6:05am
6-K
EX-99.3
wlpbm 6z2nbcj9r0dl
4 Aug 22
Results of Annual General Meeting
7:38am